Revamping the BCG revaccination strategy: Records to recall, or just call it phoenix?

References

• Rodrigues LC, Pereira SM, Cunha SS, Genser B, Ichihara MY, de Brito SC, Hijjar MA, Cruz AA, Sant’Anna C, Bierrenbach AL, et al. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. Lancet. 2005;366(9493):1290–3. doi:10.1016/S0140-6736(05)67145-0.
   PubMed Web of Science ®Google Scholar
• Barreto ML, Pereira SM, Pilger D, Cruz AA, Cunha SS, Sant’anna C, Ichihara MY, Genser B, Rodrigues LC. Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial. Vaccine. 2011;29(31):4875–7. doi:10.1016/j.vaccine.2011.05.023.
   PubMed Web of Science ®Google Scholar
• Bannister S, Sudbury E, Villanueva P, Perrett K, Curtis N. The safety of BCG revaccination: a systematic review. Vaccine. 2021;39(20):2736–45. doi:10.1016/j.vaccine.2020.08.016.
   PubMed Web of Science ®Google Scholar
• Tala-Heikkilä MM, Tuominen JE, Tala EO. Bacillus Calmette-Guérin revaccination questionable with low tuberculosis incidence. Am J Respir Crit Care Med. 1998;157(4 Pt 1):1324–7. doi:10.1164/ajrccm.157.4.9706037.
   PubMed Web of Science ®Google Scholar
• World Health Organization. BCG vaccines: WHO position paper. 2018 February. doi:10.1016/j.vaccine.2018.03.009.
   Google Scholar
• Nemes E, Geldenhuys H, Rozot V, Rutkowski KT, Ratangee F, Bilek N, Mabwe S, Makhethe L, Erasmus M, Toefy A, et al. Prevention of M. tuberculosis infection with H4: IC31 vaccine or BCG revaccination. N Engl J Med. 2018;379(2):138–49. doi:10.1056/NEJMoa1714021.
   PubMed Web of Science ®Google Scholar
• Kowalewicz-Kulbat M, Locht C. BCG and protection against inflammatory and auto-immune diseases. Expert Rev Vaccines. 2017;16(7):1–0. doi:10.1080/14760584.2017.1333906.
   PubMed Web of Science ®Google Scholar
• Junqueira-Kipnis AP, Dos Anjos LRB, Barbosa LCS, da Costa AC, Borges KCM, Cardoso ADRO, Ribeiro KM, Rosa SBA, Souza CDC, Das Neves RC, et al. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21(1):881. doi:10.1186/s13063-020-04822-0.
   PubMedGoogle Scholar
• Ramos-Martinez E, Falfán-Valencia R, Pérez-Rubio G, Andrade WA, Rojas-Serrano J, Ambrocio-Ortiz E, Galicia-Álvarez DS, Bárcenas-Montiel I, Velasco-Medina A, Velázquez-Sámano G, et al. Effect of BCG revaccination on occupationally exposed medical personnel vaccinated against SARS-CoV-2. Cells. 2021;10(11):3179. doi:10.3390/cells10113179.
   PubMed Web of Science ®Google Scholar
• Upton CM, van Wijk RC, Mockeliunas L, Simonsson USH, McHarry K, van den Hoogen G, Muller C, von Delft A, van der Westhuizen H-M, van Crevel R, et al. Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: a double-blind, randomised, controlled, phase 3 trial. EClinicalMedicine. 2022;48:101414. doi:10.1016/j.eclinm.2022.101414.
   PubMedGoogle Scholar
• Dockrell HM, Butkeviciute E. Can what have we learnt about BCG vaccination in the last 20 years help us to design a better tuberculosis vaccine? Vaccine. 2022;40(11):1525–33. doi:10.1016/j.vaccine.2021.01.068.
   PubMed Web of Science ®Google Scholar
• Jensen TM, Jensen SK, Birk NM, Rieckmann A, Hoffmann T, Benn CS, Jeppesen DL, Pryds O, Nissen TN. Determinants of Bacille Calmette-Guérin scarification in Danish children. Heliyon. 2021;7(1):e05757. doi:10.1016/j.heliyon.2020.e05757.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Meeting of the global advisory committee on vaccine safety. 2017 June 7–8. https://www.who.int/publications/i/item/WER9228.
   Google Scholar
• Aaby P, Benn CS. BCG: new life for a centenarian vaccine. Lancet Infect Dis. 2021;21(7):897–8. doi:10.1016/S1473-3099(20)30714-3.
   PubMed Web of Science ®Google Scholar
• Glynn JR, Dube A, Fielding K, Crampin AC, Kanjala C, Fine PEM, et al. The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi. Lancet Infect Dis. 2021;21(11):1590–7. doi:10.1016/S1473-3099(20)30994-4.
   PubMed Web of Science ®Google Scholar
• Pittet LF, Fritschi N, Tebruegge M, Dutta B, Donath S, Messina NL, Casalaz D, Hanekom WA, Britton WJ, Robins-Browne R, et al. Bacillus Calmette-Guérin skin reaction predicts enhanced mycobacteria-specific t-cell responses in infants: a. Am J Respir Crit Care Med. 2022;205(7):830–41. doi:10.1164/rccm.202108-1892OC.
   PubMed Web of Science ®Google Scholar
• Funch KM, Thysen SM, Rodrigues A, Martins CL, Aaby P, Benn CS, Fisker AB. Determinants of BCG scarification among children in rural Guinea-Bissau: a prospective cohort study. Hum Vaccin Immunother. 2018;14(10):1–9. doi:10.1080/21645515.2017.1421879.
   PubMed Web of Science ®Google Scholar
• Soh SB, Han PY, Tam KT, Yung CF, Liew WK, Tan NW, Chong CY, Thoon KC. Investigations into an outbreak of suppurative lymphadenitis with BCG vaccine SSI® in Singapore. Vaccine. 2014;32(44):5809–15. doi:10.1016/j.vaccine.2014.08.032.
   PubMed Web of Science ®Google Scholar
• Villanueva P, Wadia U, Crawford N, Messina NL, Kollmann TR, Lucas M, Manning L, Richmond P, Pittet LF, Curtis N, et al. Revaccination with Bacille Calmette-Guérin (BCG) is associated with an increased risk of abscess and lymphadenopathy. NPJ Vaccines. 2022;7(1):6. doi:10.1038/s41541-021-00421-5.
   PubMed Web of Science ®Google Scholar
• Roy A, Eisenhut M, Harris RJ, Rodrigues LC, Sridhar S, Habermann S, Snell L, Mangtani P, Adetifa I, Lalvani A, et al. Effect of BCG vaccination against mycobacterium tuberculosis infection in children: systematic review and meta-analysis. BMJ. 2014;349(aug04 5):g4643. doi:10.1136/bmj.g4643.
   PubMedGoogle Scholar
• Sánchez-García A, Támez-Guerra R, González-Saldivar G, Rodríguez-Gutiérrez R, Ramírez-García LA, Barrera FJ, González-González JG. The safety of BCG revaccination in the context of COVID-19. Hum Vaccin Immunother. 2023;19(3):2271760. doi:10.1080/21645515.2023.2271760.
   PubMed Web of Science ®Google Scholar
• Villanueva P, Crawford NW, Garcia Croda M, et al. Safety of BCG vaccination and revaccination in healthcare workers. Hum Vaccin Immunother. 2023;19(2):2239088. doi:10.1080/21645515.2023.2239088.
   PubMed Web of Science ®Google Scholar
• Yamoah P, Boamah Mensah K, Padayachee N, Bangalee V, Oosthuizen F. Assessment of adherence to pre-vaccination precautions and AEFI reporting practices during BCG vaccination in 4 hospitals in Ghana. Hum Vaccin Immunother. 2023;19(1):2199654. doi:10.1080/21645515.2023.2199654.
   PubMed Web of Science ®Google Scholar
• Savul S, Duthie S. A retrospective audit of neonatal BCG vaccination in Grampian, Scotland. Hum Vaccin Immunother. 2023;19(3):2281737. doi:10.1080/21645515.2023.2281737.
   PubMed Web of Science ®Google Scholar
• Silveira MF, Buffarini R, Bertoldi AD, Santos IS, Barros AJD, Matijasevich A, Menezes AMB, Gonçalves H, Horta BL, Barros FC, et al. The emergence of vaccine hesitancy among upper-class Brazilians: results from four birth cohorts, 1982–2015. Vaccine. 2020;38(3):482–8. doi:10.1016/j.vaccine.2019.10.070.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Recommendations to assure the quality, safety and efficacy of BCG vaccines. Geneva: WHO; 2013. https://www.who.int/publications/i/item/9789241209793.
   Google Scholar
• Angelidou A, Conti MG, Diray-Arce J, Benn CS, Shann F, Netea MG, Liu M, Potluri LP, Sanchez-Schmitz G, Husson R, et al. Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation. Vaccine. 2020;38(9):2229–40. doi:10.1016/j.vaccine.2019.11.060.
   PubMed Web of Science ®Google Scholar